107 related articles for article (PubMed ID: 25675742)
1. [Modern methods of diagnosis of thrombophylic states and complex treatment of patients with thrombotic complications of severe forms of varicose disease].
Shchukin SP
Klin Khir; 2014 Nov; (11):38-41. PubMed ID: 25675742
[TBL] [Abstract][Full Text] [Related]
2. [Thrombotic complications of severe forms of varicose disease: modern approach to diagnosis and treatment of hereditary thrombophilia and immunohistochemical peculiarities of vascular wall].
Chernukha LM; Shchukin SP; Archakova TM
Klin Khir; 2014 Oct; (10):31-6. PubMed ID: 25675784
[TBL] [Abstract][Full Text] [Related]
3. [Thrombotic complications in severe forms of varicose disease: diagnosis, surgical treatment, using miniinvasive methods].
Chernukha LM; Shchukin SP
Klin Khir; 2015 Jan; (1):35-7. PubMed ID: 25842677
[TBL] [Abstract][Full Text] [Related]
4. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.
Lane DA; Grant PJ
Blood; 2000 Mar; 95(5):1517-32. PubMed ID: 10688804
[No Abstract] [Full Text] [Related]
5. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
6. [Rare thrombophilic states].
Emmerich J
Rev Med Interne; 2008 Jun; 29(6):482-5. PubMed ID: 18394759
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
[TBL] [Abstract][Full Text] [Related]
8. Genetic thrombophilia.
Feero WG
Prim Care; 2004 Sep; 31(3):685-709, xi. PubMed ID: 15331254
[TBL] [Abstract][Full Text] [Related]
9. Role of thrombophilic gene polymorphisms in branch retinal vein occlusion.
Weger M; Renner W; Steinbrugger I; Cichocki L; Temmel W; Stanger O; El-Shabrawi Y; Lechner H; Schmut O; Haas A
Ophthalmology; 2005 Nov; 112(11):1910-5. PubMed ID: 16157382
[TBL] [Abstract][Full Text] [Related]
10. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
Yenicesu GI; Cetin M; Ozdemir O; Cetin A; Ozen F; Yenicesu C; Yildiz C; Kocak N
Am J Reprod Immunol; 2010 Feb; 63(2):126-36. PubMed ID: 19906129
[TBL] [Abstract][Full Text] [Related]
11. Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease annotation.
Greaves M; Baglin T
Br J Haematol; 2000 Jun; 109(4):699-703. PubMed ID: 10929018
[No Abstract] [Full Text] [Related]
12. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.
Al-Allawi NA; Badi AI; Goran MA; Nerweyi FF; Ballo HM; Al-Mzury NT
Genet Test Mol Biomarkers; 2015 Sep; 19(9):500-4. PubMed ID: 26196588
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with the development of superficial vein thrombosis in patients with varicose veins.
Karathanos C; Exarchou M; Tsezou A; Kyriakou D; Wittens C; Giannoukas A
Thromb Res; 2013 Jul; 132(1):47-50. PubMed ID: 23768449
[TBL] [Abstract][Full Text] [Related]
14. Thrombophilia related issues in women and children.
Hoffman R; Brenner B
Semin Thromb Hemost; 2005 Feb; 31(1):97-103. PubMed ID: 15706481
[TBL] [Abstract][Full Text] [Related]
15. Impact of screening on thrombophilia for patients with venous thrombosis.
Paschôa AF; Guillaumon AT
Int Angiol; 2006 Mar; 25(1):52-9. PubMed ID: 16520725
[TBL] [Abstract][Full Text] [Related]
16. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
Cosmi B; Legnani C; Pengo V; Ghirarduzzi A; Testa S; Poli D; Prisco D; Tripodi A; Palareti G;
Thromb Haemost; 2013 Mar; 109(3):510-6. PubMed ID: 23306310
[TBL] [Abstract][Full Text] [Related]
17. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.
Glueck CJ; Wang P
Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459
[TBL] [Abstract][Full Text] [Related]
18. Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family.
Santamaría A; Soria JM; Tirado I; Mateo J; Coll I; Souto JC; Fontcuberta J
Thromb Haemost; 2005 Jun; 93(6):1193-5. PubMed ID: 15968408
[No Abstract] [Full Text] [Related]
19. Molecular analysis of thrombophilic risk factors in patients with dural arteriovenous fistulas.
Kraus JA; Stüper BK; Müller J; Nahser HC; Klockgether T; Berlit P; Harbrecht U
J Neurol; 2002 Jun; 249(6):680-2. PubMed ID: 12111299
[TBL] [Abstract][Full Text] [Related]
20. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
